SLAM/CD150 Antibody (IPO-3)

Product Discontinued

SLAM/CD150 Antibody (IPO-3) Summary

• Immunogen: Human CD150
• Isotype: IgG1
• Clonality: Monoclonal
• Host: Mouse
• Gene: SLAMF1
• Purity: Protein A or G purified

Applications/Dilutions

• Dilutions:
  • Flow Cytometry
  • Immunocytochemistry/ Immunofluorescence
  • Immunohistochemistry

Reactivity Notes

Human

Packaging, Storage & Formulations

• Storage: Store at 4C. Do not freeze.
• Buffer: 0.1 ml PBS (pH 7.2)
• Preservative: No Preservative
• Purity: Protein A or G purified

Alternate Names for SLAM/CD150 Antibody (IPO-3)

• CD 150
• CD150
• CD150IPO-3
• CDw150
• IPO-3
• signaling lymphocytic activation molecule family member 1
• signaling lymphocytic activation molecule
• SLAM
• SLAMCD150 antigen
• SLAMF1

Background

Revealing the molecular signals involved in B and T cell activation is critical to the future discovery of therapeutics that can augment cell-mediated immune responses to disease.CD150 is a type I transmembrane glycoprotein that is involved in signal transduction of antigen specific responses in B and T cells. It is expressed by activated B cells isolated from tonsils and peripheral blood, B cells in germinal centers and mantle zone of lymph nodes, immature thymocytes, and CD45RO+CD45RA- subpopulation of T cells. This antibody has been used to detect CD150 in neoplastic cells from diffuse large B-cell lymphoma, Hodgkin's disease, hairy cell leukemia, and some tumors of ectodermal origin.

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Bioinformatics

• Gene Symbol: SLAMF1